FDA Adverse Event Malfunction Summary report: N

BD INSYTE AUTOGUARD

MDR report key: 21062864 · Received January 2, 2025

Report

Report Number
1710034-2024-01569
Event Type
Malfunction
Date Received
January 2, 2025
Date of Event
December 5, 2024
Report Date
December 17, 2024
Manufacturer
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Product Code
FPA
UDI-DI
00382903851003
PMA / PMN Number
K013621
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE HISTORY RECORD REVIEW WAS COMPLETED BY OUR QUALITY ENGINEER TEAM FOR PROVIDED MATERIAL NUMBER 385100 AND LOT NUMBER 3093406. THE REVIEW DID NOT REVEAL ANY DETECTED ABNORMALITIES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THIS DEFECT AND ALL QUALITY TESTS WERE FOUND TO BE WITHIN SPECIFICATION. AS A SAMPLE WAS UNAVAILABLE FOR RETURN, A THOROUGH SAMPLE INVESTIGATION COULD NOT BE COMPLETED. BASED ON THE INVESTIGATION RESULTS, AN EXACT CAUSE FOR THIS INCIDENT COULD NOT BE IDENTIFIED. THERE ARE QUALITY CONTROLS CURRENTLY IN PLACE TO DETECT THIS TYPE OF DEFECT DURING THE PRODUCTION PROCESS. FURTHER ACTION HAS NOT BEEN DETERMINED NECESSARY AT THIS TIME. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. OUR QUALITY TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD Q-SYTE CLOSED LUER ACCESS DEVICE CONNECTER RUPTURES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THE TEACHER OF THE SECOND WARD OF CHEMOTHERAPY ONCOLOGY FOUND WHEN USING IT THAT THE JOINTS RUPTURED. PRODUCT REASON (INCLUDING INSTRUCTIONS, ETC.) REPLACE THE PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1610710 BD INSYTE AUTOGUARD PERIPHERAL IV CATHETERS FPA BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 3093406 00382903851003

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown